Bristol-Myers Squibb CoBMY:NYQ

50.95
0.04 / 0.08%
6.52m
20.45%
0.4484
Close in USDToday's changeShares traded1 year changeBeta
As of Apr 23 2014 21:04 BST.Data delayed by at least 15 minutes.

Summary

On Wednesday, Bristol-Myers Squibb Co (BMY:NYQ) closed at 50.95, 11.38% below its 52-week high of 57.49, set on Mar 06, 2014.

52-week range
Today
39.18
May 01 2013
57.49
Mar 06 2014
Markit short selling activity
Low
Medium
High
Open51.16
Day high51.16
Day low50.69
Bid51.01
Offer51.49
Previous close50.99
Average volume8.56m
Shares outstanding1.66bn
Free float1.65bn
P/E (TTM)32.96
Market cap84.49bn USD
EPS (TTM)1.55 USD
Annual div (TTM)1.44 USD
Annual div yield (TTM)2.82%
Div ex-dateApr 02 2014
Div pay-dateMay 01 2014

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Bristol-Myers Squibb Co+3.75%-2.13%+4.06%+20.45%+152.60%
S&P 500 INDEX+0.93%+0.70%+7.63%+19.05%+120.63%
USA/HEALTH CARE+1.77%-0.98%+8.82%+16.80%--
USA/PHARMACEUTICALS+3.14%+1.58%+11.54%+14.00%--
As of Apr 23 2014 21:04 BST.Data delayed by at least 15 minutes.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.